In a crowded and challenging business environment, with a continuous strive to create a win-win situation, since 1999, Nualter Group of Companies is progressing hand in hand with all business associates, whether they are small or large pharmaceutical companies, and helping them with their production needs.
At Nualter, our core business philosophy is centred on achieving customer satisfaction. We strongly believe that success and profitability go hand in hand. Our product line is characterized by a strong emphasis on research, innovation, and technology. Our experience, market knowledge, pharmaceutical segment expertise, and technical proficiency enable us to provide the right solutions to our clients as an extension of our own business.
Nualter is renowned for developing new formulations, conducting bioequivalence studies and clinical trials, and obtaining approval from the Drug Controller General of India (DCGI) for manufacturing and marketing new molecules. We also offer new formulations developed with advanced technology under our customers' brand names. Additionally, we manufacture innovative and technology-driven products.
From the procurement of raw materials to the final stages of product packaging, we enforce rigorous quality control measures. This meticulous approach allows us to deliver products that not only meet but surpass our customers' expectations.
Nualter attributes its substantial growth to key factors such as quality, affordability, and unwavering customer satisfaction. Since the initial infrastructure development phase, our company has been dedicated to achieving all-encompassing excellence in manufacturing, marketing, and ensuring customer contentment.
Recognizing the critical link between our products and the health and safety of our customers, we are a leading Pharma Manufacturing and Marketing company committed to upholding stringent international standards. Our team of experts meticulously oversees every stage of the production process, ensuring consistent quality and compliance. Regular audits of our manufacturing facilities are conducted to ensure adherence to our high- quality standards.
From the Managing Director’s Desk
I am delighted to share that Nualter Group of Companies has evolved into a distinguished pharmaceutical brand, excelling in allopathic, ayurvedic, herbal, and veterinary product manufacturing. As the director, I take pride in our leading position in the pharmaceutical franchise business in India, where we continuously set industry standards and provide essential healthcare solutions.
Our certifications are a testament to our unwavering commitment to producing top-quality products that align seamlessly with global standards and regulations. This achievement reflects our dedication to excellence in every facet of our operations.
I extend my deepest gratitude to our supportive family, the encouraging feedback from our esteemed clients, and, most importantly, the tireless efforts of our dedicated team. Together, we have propelled Nualter Group to its current position, and I am confident that our journey of innovation and quality will continue to shape the future of medicine and wellness.
Manufacturing excellence at Nualter begins with our expansive manufacturing area, featuring state-of-the-art automatic machines for the production of tablets, capsules, liquids, dry syrups, and bolus (vet.). Our entire facility meticulously manages clean air and differential air pressure within the manufacturing area, demarcated for both Beta and non- Beta sections, under the control of an air handling unit (AHU).
Nualter's most sophisticated and fully automatic manufacturing plants encompass approximately 85,000 sq ft. Equipped with the latest machinery and lab testing equipment, the facilities comply with ISO 9000-2015, GMP, GLP, and WHO standards, ensuring advanced specifications in quality production and packaging.
The company proudly owns four manufacturing units and has over 350 third-party manufacturing partners who are immensely satisfied with the quality and services. The infrastructure, production process, and strict adherence to quality control measures reaffirm Nualter's manufacturing excellence.
At Nualter, we're strong believers in the power of innovation for achieving success in the pharma industry. We're always seeking new technology and pushing limits to come up with new and innovative solutions that cater to our clients' needs while addressing gaps in the market. Our top-notch research & development facility is packed with cutting-edge tools and technology to support our innovative endeavors. Plus, we foster a work environment that promotes creativity and teamwork, fueling innovation throughout our entire company.
In today's fast-paced business world, reliability and punctuality are crucial, and we are committed to ensuring that our customers can always rely on us for timely delivery and exceptional service. Our word is our bond, and we will never let our customers down. Our top priority is customer satisfaction, and we are dedicated to delivering products that exceed expectations.
A strong sense of responsibility to improve world health and well-being motivates Nualter. We strive to develop and produce medications that improve lives, alleviate suffering, and address unmet medical needs. Our mission is to be a trusted partner in enhancing the quality of healthcare worldwide.
Nualter envisions a future where it leads the pharmaceutical industry in developing cutting-edge drugs and healthcare solutions that transform lives, address unmet medical needs, and advance global well-being.
We prioritize uncompromising quality in pharmaceutical manufacturing, ensuring the safety and efficacy of every product.
Embracing diversity and scale, we lead with innovation to address global healthcare needs.
Striving for efficiency, we optimize operations to deliver reliable and affordable medications.
Dedicated to exceptional service, we ensure timely and customer- centric delivery to our partners and patients.
Our focus on patients drives every aspect of our work, shaping research & development for positive healthcare outcomes.